NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers - PubMed (original) (raw)

Clinical Trial

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers

A K Malhotra et al. Neuropsychopharmacology. 1996 May.

Abstract

A rapidly growing body of preclinical data has implicated the glutamatergic N-methyl-d-aspartate (NMDA) receptor in memory and other cognitive processes. There is comparatively less information about this receptor system in human cognition. We examined the effects of subanesthetic doses of ketamine, a noncompetitive NMDA receptor antagonist, on two forms of memory, free recall and recognition, as well as attention and behavior in a double-blind, placebo-controlled, 1-hour infusion in 15 healthy volunteers. Ketamine produced decrements in free recall, recognition memory, and attention. In addition, ketamine induced a brief psychosis in our healthy volunteers marked by thought disorder and withdrawal-retardation. Ketamine-induced memory impairments were not accounted for by changes in subject's attention and were not significantly related to psychosis ratings. These data suggest that the NMDA receptor plays a direct role in two types of explicit memory. The implications of these data for the pathophysiology of schizophrenia are discussed.

PubMed Disclaimer

Cited by

Glycine transporter inhibitor attenuates the psychotomimetic effects of ketamine in healthy males: preliminary evidence.
D'Souza DC, Singh N, Elander J, Carbuto M, Pittman B, Udo de Haes J, Sjogren M, Peeters P, Ranganathan M, Schipper J. D'Souza DC, et al. Neuropsychopharmacology. 2012 Mar;37(4):1036-46. doi: 10.1038/npp.2011.295. Epub 2011 Nov 23. Neuropsychopharmacology. 2012. PMID: 22113087 Free PMC article. Clinical Trial.
Capturing the angel in "angel dust": twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans.
Moghaddam B, Krystal JH. Moghaddam B, et al. Schizophr Bull. 2012 Sep;38(5):942-9. doi: 10.1093/schbul/sbs075. Epub 2012 Aug 16. Schizophr Bull. 2012. PMID: 22899397 Free PMC article. Review.
Mutation screening of GRIN2B in schizophrenia and autism spectrum disorder in a Japanese population.
Takasaki Y, Koide T, Wang C, Kimura H, Xing J, Kushima I, Ishizuka K, Mori D, Sekiguchi M, Ikeda M, Aizawa M, Tsurumaru N, Iwayama Y, Yoshimi A, Arioka Y, Yoshida M, Noma H, Oya-Ito T, Nakamura Y, Kunimoto S, Aleksic B, Uno Y, Okada T, Ujike H, Egawa J, Kuwabara H, Someya T, Yoshikawa T, Iwata N, Ozaki N. Takasaki Y, et al. Sci Rep. 2016 Sep 12;6:33311. doi: 10.1038/srep33311. Sci Rep. 2016. PMID: 27616045 Free PMC article.
Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia.
Egan MF, Straub RE, Goldberg TE, Yakub I, Callicott JH, Hariri AR, Mattay VS, Bertolino A, Hyde TM, Shannon-Weickert C, Akil M, Crook J, Vakkalanka RK, Balkissoon R, Gibbs RA, Kleinman JE, Weinberger DR. Egan MF, et al. Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12604-9. doi: 10.1073/pnas.0405077101. Epub 2004 Aug 13. Proc Natl Acad Sci U S A. 2004. PMID: 15310849 Free PMC article.
On the safety of repeated ketamine infusions for the treatment of depression: Effects of sex and developmental periods.
Strong CE, Kabbaj M. Strong CE, et al. Neurobiol Stress. 2018 Sep 21;9:166-175. doi: 10.1016/j.ynstr.2018.09.001. eCollection 2018 Nov. Neurobiol Stress. 2018. PMID: 30450382 Free PMC article. Review.

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers - PubMed (original) (raw)